Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma
- PMID: 29554261
- DOI: 10.1001/jama.2018.2029
Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma
Comment on
-
Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis.JAMA. 2018 Apr 10;319(14):1473-1484. doi: 10.1001/jama.2018.2757. JAMA. 2018. PMID: 29554174 Free PMC article.
-
Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.JAMA. 2018 Apr 10;319(14):1485-1496. doi: 10.1001/jama.2018.2769. JAMA. 2018. PMID: 29554195 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical